Dementias Platform UK is to host access to a new cellular model platform that will help researchers explore risk factors that contribute to the development of Alzheimer's disease.
People consume less alcohol as the price of food increases, suggesting this may influence the decision to buy it, according to a new study led by Cardiff University and carried out in the DPUK Data Portal.
Researchers have developed a more efficient method of assessing symptom change in people with ulcerative colitis \u2013 a form of inflammatory bowel disease (IBD).
People who experienced head injuries in their 50s or younger score lower than expected on cognitive tests at age 70, according to a study led by UCL researchers and part-funded by DPUK.
Dementias Platform UK (DPUK) has been featured as a case study in the latest report from Alzheimer Europe, a non-profit, non-governmental organisation aiming to make dementia a priority across Europe.
Hearing loss is known to increase a person\u2019s risk of dementia, but new research demonstrates that using hearing aids for hearing difficulties can protect against the condition.
A decline in cognitive ability is one of the hallmarks of dementia. But how do researchers and clinicians accurately measure these changes in symptoms?
Researchers based at UCL have found that blood tests measuring the protein amyloid \u2013 a hallmark of Alzheimer's disease \u2013 could radically reduce the cost of clinical trials and potentially open the door to treating the disease earlier.
Researchers at Oxford University are recruiting volunteers aged 50+ who have either mild cognitive impairment (MCI) or early-stage dementia, as well as neurologically healthy people as an essential comparison to those with memory impairment.
A new paper details what the DPUK volunteer recontact register is and how it can be used by researchers to recruit highly characterised participants to brain health studies.
A team of researchers from the University of Oxford and the Alzheimer Center Amsterdam has successfully predicted the Alzheimer's disease biomarkers present in cognitively healthy individuals from their risk factors.
The UK\u2019s Medical Research Council (MRC) \u2013 part of UK Research and Innovation \u2013 has today confirmed a multi-million-pound renewal of funding for Dementias Platform UK (DPUK), in partnership with industry and the third sector.
DPUK has this week launched a new report summarising its achievements to date and looking ahead to its future role at the leading edge of dementia research.
The University of Sheffield\u2019s new PET-MR scanner is to become part of the DPUK imaging network, supporting research into the detection and treatment of dementia.
![\"An](\"https://www.dementiasplatform.uk/news-and-media/latest-news/new-stem-cell-platform-launched-to-transform-understanding-of-risk-factors-for-alzheimers-disease/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n